Tech Company Financing Transactions
Mazen Animal Health Funding Round
Mazen Animal Health, operating out of Ames, secured $11 million from AgFunder and Fall Line Capital.
Transaction Overview
Company Name
Announced On
5/31/2022
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
AgFunder (Lead Investor)
Fall Line Capital (Lead Investor)
Proceeds Purpose
The funding will also help with plans to scale up their ability to manufacture the vaccine at commercial scale, while advancing a pipeline of other vaccines such as one for coccidiosis in poultry among others.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
ISU Research Park, 1805 Collaboration Place 1250
Ames, IA 50010-9166
USA
Ames, IA 50010-9166
USA
Phone
Website
Email Address
Overview
Mazen Animal Health is a new company focused on developing, delivering and commercializing novel biological vaccines and therapeutics that disrupt the status quo and address complex or unsolved challenges in animal health and protein production. Our first disruptive solution is a reinvention of vaccines with a novel technology platform that will shift the paradigm in disease prevention.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jennifer Filbey
Chief Financial Officer
David Morrison
Co-Founder
John Howard
Browse more venture capital transactions:
Prev: 5/30/2022: iFarmer venture capital transaction
Next: 5/31/2022: Seemplicity venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs